Latest filing published 07 Oct 2025 for GlucoTrack, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Paul Goode appears in our data through filings on GlucoTrack, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 14 November 2024 to 25 March 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 7 October 2025 came the latest disclosure, a transaction in GlucoTrack, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations